These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2569998)

  • 1. A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria.
    Gale AE; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():25B-27B. PubMed ID: 2569998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
    van Joost T; Blog FB; Westerhof W; Jansen FC; Starink TM; den Boer MS; Kuneman JJ; Harvey SG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria.
    Leyh F; Harvey SG; Gibson JR; Manna VK
    J Int Med Res; 1989; 17 Suppl 2():22B-24B. PubMed ID: 2569997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study.
    Boyle J; Marks P; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():9B-13B. PubMed ID: 2570004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrivastine--an evaluation of initial and peak activity in human skin.
    Marks P; Manna VK; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study.
    Kobza Black A; Aboobaker J; Gibson JR; Harvey SG; Marks P
    Acta Derm Venereol; 1988; 68(6):541-4. PubMed ID: 2467496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria.
    Neittaanmäki H; Fräki JE; Gibson JR
    Dermatologica; 1988; 177(2):98-103. PubMed ID: 2901993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged treatment with acrivastine for seasonal allergic rhinitis.
    Bruno G; D'Amato G; Del Giacco GS; Locci F; Gale NM; Errigo E; Melillo G
    J Int Med Res; 1989; 17 Suppl 2():40B-46B. PubMed ID: 2570001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. French multicentre double-blind study to evaluate the efficacy and safety of acrivastine as compared with terfenadine in seasonal allergic rhinitis.
    Gervais P; Bruttman G; Pedrali P; Charpin J; Michel FB; Grilliat JP
    J Int Med Res; 1989; 17 Suppl 2():47B-53B. PubMed ID: 2570002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders.
    Brogden RN; McTavish D
    Drugs; 1991 Jun; 41(6):927-40. PubMed ID: 1715267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acrivastine in allergic rhinitis: a review of clinical experience.
    Bojkowski CJ; Gibbs TG; Hellstern KH; Major EW; Mullinger B
    J Int Med Res; 1989; 17 Suppl 2():54B-68B. PubMed ID: 2570003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of four antihistamines in chronic urticaria.
    Youngchaiyud U
    J Med Assoc Thai; 1988 Oct; 71(10):548-52. PubMed ID: 2907911
    [No Abstract]   [Full Text] [Related]  

  • 14. A cross-over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis.
    Meran A; Morse J; Gibbs TG
    Rhinology; 1990 Mar; 28(1):33-40. PubMed ID: 1970907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of the novel antihistamine BW 825C in the treatment of chronic idiopathic urticaria. A placebo-controlled study.
    Gibson JR; Harvey SG; Barth JH; Moss MY; Burke CA
    Dermatologica; 1984; 169(4):179-83. PubMed ID: 6149965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double-blind, placebo-controlled study.
    Juhlin L; Gibson JR; Harvey SG; Huson LW
    Int J Dermatol; 1987 Dec; 26(10):653-4. PubMed ID: 2892806
    [No Abstract]   [Full Text] [Related]  

  • 17. Acrivastine: a review of its dermatopharmacology and clinical activity.
    Gibson JR; Manna VK; Salisbury J
    J Int Med Res; 1989; 17 Suppl 2():28B-34B. PubMed ID: 2475374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of idiopathic urticaria with H1 + H2 antagonists. A crossover double blind long-term study].
    Diller G; Orfanos CE
    Z Hautkr; 1983 Jun; 58(11):785-93. PubMed ID: 6136132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acrivastine in seasonal allergic rhinitis: two randomized crossover studies to evaluate efficacy and safety.
    Gibbs TG; Irander K; Salo OP
    J Int Med Res; 1988; 16(6):413-9. PubMed ID: 2906886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
    Paul E; Bödeker RH
    Ann Allergy; 1989 Apr; 62(4):318-20. PubMed ID: 2565098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.